MX2018006828A - Usos de poblaciones expandidas de celulas madre/progenitoras hematopoyeticas. - Google Patents

Usos de poblaciones expandidas de celulas madre/progenitoras hematopoyeticas.

Info

Publication number
MX2018006828A
MX2018006828A MX2018006828A MX2018006828A MX2018006828A MX 2018006828 A MX2018006828 A MX 2018006828A MX 2018006828 A MX2018006828 A MX 2018006828A MX 2018006828 A MX2018006828 A MX 2018006828A MX 2018006828 A MX2018006828 A MX 2018006828A
Authority
MX
Mexico
Prior art keywords
progenitor cells
hematopoietic stem
reduce
expanded populations
following
Prior art date
Application number
MX2018006828A
Other languages
English (en)
Inventor
Delaney Colleen
Original Assignee
Hutchinson Fred Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hutchinson Fred Cancer Res filed Critical Hutchinson Fred Cancer Res
Publication of MX2018006828A publication Critical patent/MX2018006828A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/12—Animals modified by administration of exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0381—Animal model for diseases of the hematopoietic system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses

Abstract

Se describen los usos de células madre/progenitoras hematopoyéticas (HSPC) de sangre de cordón expandidas. Ejemplos incluyen reducir el rechazo de trasplante, inducir inmunotolerancia, reducir la alimentación de nutrición parenteral total (TPN), el uso de opioides, la mucositis y la hospitalización después de un procedimiento médico y reducir la enfermedad de injerto versus huésped (GVHD) después de un trasplante alogénico.
MX2018006828A 2015-12-04 2016-12-05 Usos de poblaciones expandidas de celulas madre/progenitoras hematopoyeticas. MX2018006828A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562263470P 2015-12-04 2015-12-04
US201562263573P 2015-12-04 2015-12-04
PCT/US2016/064908 WO2017096347A1 (en) 2015-12-04 2016-12-05 Uses of expanded populations of hematopoietic stem/progenitor cells

Publications (1)

Publication Number Publication Date
MX2018006828A true MX2018006828A (es) 2018-08-09

Family

ID=58797992

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018006828A MX2018006828A (es) 2015-12-04 2016-12-05 Usos de poblaciones expandidas de celulas madre/progenitoras hematopoyeticas.

Country Status (11)

Country Link
US (1) US10813949B2 (es)
EP (1) EP3384006A4 (es)
JP (2) JP2018537472A (es)
KR (1) KR20180085018A (es)
CN (1) CN108473949A (es)
AU (1) AU2016364934A1 (es)
BR (1) BR112018011327A2 (es)
CA (1) CA3005767A1 (es)
MX (1) MX2018006828A (es)
RU (1) RU2747728C2 (es)
WO (1) WO2017096347A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110621321A (zh) 2017-03-15 2019-12-27 浩康生物系统公司 用于造血干细胞移植的组合物和方法
CA3063674A1 (en) 2017-05-16 2018-11-22 Gamida-Cell Ltd. Selection and use of umbilical cord cell fractions suitable for transplantation
CA3064055A1 (en) 2017-05-16 2018-11-22 Gamida-Cell Ltd. Selection and use of umbilical cord cell fractions suitable for transplantation
US11697799B2 (en) 2019-04-15 2023-07-11 Ossium Health, Inc. System and method for extraction and cryopreservation of bone marrow
CN110564687B (zh) * 2019-11-05 2020-04-03 诺未科技（北京）有限公司 用于扩增造血干细胞的组合物、培养基、方法和试剂盒
WO2022020210A1 (en) 2020-07-18 2022-01-27 Ossium Health, Inc. Permeation of whole vertebral bodies with a cryoprotectant using vacuum assisted diffusion
AU2021360590A1 (en) * 2020-10-14 2023-06-15 Ossium Health, Inc. Systems and methods for extraction and cryopreservation of bone marrow
CN116583594A (zh) * 2020-10-14 2023-08-11 奥瑟姆健康公司 用于骨髓的提取和低温保藏的系统和方法
EP4262831A1 (en) 2020-12-18 2023-10-25 Ossium Health, Inc. Methods of cell therapies
WO2023283404A1 (en) * 2021-07-09 2023-01-12 Temple University - Of The Commonwealth System Of Higher Education Myocardial wound healing post ischemic injury

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004681B1 (en) 1987-11-12 2000-04-11 Biocyte Corp Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
IL101728A (en) 1991-05-03 2007-08-19 Univ Yale Human Abandonment and Delta, Restrictive Areas of Effect in Tophoric Proteins, and Methods Based on Them
IE20030749A1 (en) 1991-05-03 2003-11-12 Indiana University Foundation Human notch and delta binding domains in torporythmic proteins, and methods based thereon
US5856441A (en) 1991-05-03 1999-01-05 Yale University Serrate fragments and derivatives
US5869282A (en) 1991-12-11 1999-02-09 Imperial Cancer Research Technology, Ltd. Nucleotide and protein sequences of the serrate gene and methods based thereon
WO1993012141A1 (en) 1991-12-11 1993-06-24 Yale University Nucleotide and protein sequences of the serrate gene and methods based thereon
WO1995003062A1 (en) * 1993-07-21 1995-02-02 Cellpro, Incorporated Methods and compositions for preventing immune rejection of solid organ grafts
AU4236296A (en) * 1994-11-10 1996-06-06 Fred Hutchinson Cancer Research Center Intrathymic stem cell implantation
US5780300A (en) 1995-09-29 1998-07-14 Yale University Manipulation of non-terminally differentiated cells using the notch pathway
US6544506B2 (en) * 2000-01-05 2003-04-08 Yeda Research & Development Co. Ltd. Veto cells effective in preventing graft rejection and devoid of graft versus host potential
US7399633B2 (en) 2000-10-27 2008-07-15 Fred Hutchinson Cancer Research Center Methods for immortalizing cells
US20020132343A1 (en) 2001-03-19 2002-09-19 Clark Lum System and method for delivering umbilical cord-derived tissue-matched stem cells for transplantation
US7147626B2 (en) 2004-09-23 2006-12-12 Celgene Corporation Cord blood and placenta collection kit
WO2006047569A2 (en) * 2004-10-25 2006-05-04 Cellerant Therapeutics, Inc. Methods of expanding myeloid cell populations and uses thereof
CN101421393B (zh) 2006-02-14 2013-08-14 塞勒兰特治疗公司 提高造血干细胞植入的方法和组合物
WO2008036374A2 (en) 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
CN103356711A (zh) 2007-02-12 2013-10-23 人类起源公司 利用胎盘干细胞治疗炎性疾病
WO2011127470A1 (en) * 2010-04-09 2011-10-13 Fred Hutchinson Cancer Research Center Compositions and methods for providing hematopoietic function without hla matching
CA3090548A1 (en) * 2010-04-09 2011-10-13 Fred Hutchinson Cancer Research Center Compositions and methods for providing hematopoietic function
AU2012347534B2 (en) * 2011-12-08 2018-01-25 Fred Hutchinson Cancer Research Center Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
WO2013093919A2 (en) * 2011-12-22 2013-06-27 Yeda Research And Development Co. Ltd. A combination therapy for a stable and long term engraftment using specific protocols for t/b cell depletion
GB2502589B (en) 2012-05-31 2019-09-11 Denso Corp Method for an in-vehicle apparatus, an in-vehicle apparatus and a vehicle
US20150283235A1 (en) * 2012-11-05 2015-10-08 Regimmune Corporation Immune-tolerance inducer

Also Published As

Publication number Publication date
AU2016364934A1 (en) 2018-06-07
RU2747728C2 (ru) 2021-05-13
RU2018124303A (ru) 2020-01-13
CA3005767A1 (en) 2017-06-08
KR20180085018A (ko) 2018-07-25
JP2018537472A (ja) 2018-12-20
WO2017096347A1 (en) 2017-06-08
US10813949B2 (en) 2020-10-27
US20180353541A1 (en) 2018-12-13
BR112018011327A2 (pt) 2018-12-04
EP3384006A1 (en) 2018-10-10
JP2022088551A (ja) 2022-06-14
CN108473949A (zh) 2018-08-31
RU2018124303A3 (es) 2020-08-06
EP3384006A4 (en) 2019-06-12

Similar Documents

Publication Publication Date Title
MX2018006828A (es) Usos de poblaciones expandidas de celulas madre/progenitoras hematopoyeticas.
IL280743B (en) Methods for enriching and producing immune cell populations for stress treatment
MX2019014009A (es) Metodos mejorados para la elaboracion de terapias celulares adoptivas.
MX2021012636A (es) Terapeuticos dirigidos a la glucosa.
PH12014502767A1 (en) Interleukin-2 fusion proteins and uses thereof
BR112016024911A2 (pt) composições de proteínas solúveis e métodos de sua produçâo
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
MX2016014144A (es) Composiciones de proteina concentrada y metodos para su elaboracion y uso.
MX2018002543A (es) Composiciones que comprenden compuestos de urolitina.
PL3635096T3 (pl) Sposób izolacji subpopulacji komórek progenitorowych serca i związane z nimi zastosowania w dziedzinie medycyny
PH12016501689A1 (en) Tatk-cdkl5 fusion proteins, compositions, formulations, and use thereof
WO2015123493A3 (en) Compositions and methods for modulatuion of immune response
MY197524A (en) System of multiple bags and method for the preparation of hemocomponents
PH12020550651A1 (en) Gender specific synthetic nutritional compositions comprising lycopene and nutritional systems comprising them
PH12017500018A1 (en) Myo-inositol and probiotics, and their use
WO2014133728A3 (en) Hhla2 as a novel inhibitor of human immune system and uses thereof
IN2014DN08964A (es)
MX2020002552A (es) Métodos y composiciones para preparar proteína surfactante d (sp-d).
MX2020002551A (es) Metodos, composiciones y celulas para preparar proteina surfactante d (sp-d).
PH12018500164A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
PH12018500165A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
Bernardi et al. Post-remission intensive treatment after induction chemotherapy is feasible in selected elderly patients with acute myeloid leukemia and age≥ 75 years: a retrospective analysis of the Rete Ematologica Lombarda
EP3324735A4 (en) Article of manufacture and methods for increasing survival of red blood cells
Kurokohchi et al. Palpitations after Dinner
Sengsayadeth et al. Age is more than a number